These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8813483)

  • 41. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of octreotide in the treatment of pancreatic fistula].
    Zelli GP
    Minerva Chir; 1992 Apr; 47(8):735-6. PubMed ID: 1351279
    [No Abstract]   [Full Text] [Related]  

  • 43. Somatostatin analogues for the treatment of enterocutaneous fistulas: a systematic review and meta-analysis.
    Coughlin S; Roth L; Lurati G; Faulhaber M
    World J Surg; 2012 May; 36(5):1016-1029. PubMed ID: 22419412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection.
    Rosenberg L; MacNeil P; Turcotte L
    J Gastrointest Surg; 1999; 3(3):225-32. PubMed ID: 10481115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pancreatic fistulas: evaluation of medical treatment in 50 observed cases].
    Pederzoli P; Bassi C; Manossi E; Orcalli F; Briani GF; Schönsberg A; Ferrari M; Tenchini P; Lamberti L; Carpi I
    Chir Ital; 1983 Dec; 35(6):993-1002. PubMed ID: 6151877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of somatostatin-14 and its analogues in the management of gastrointestinal fistulae: clinical data.
    Hesse U; Ysebaert D; de Hemptinne B
    Gut; 2001 Dec; 49 Suppl 4(Suppl 4):iv11-21. PubMed ID: 11878789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin for the prevention of complications following pancreatoduodenectomy.
    Gouillat C
    Digestion; 1999; 60 Suppl 3():59-63. PubMed ID: 10567790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
    Delmont J; Hastier P; Dumas R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
    [No Abstract]   [Full Text] [Related]  

  • 49. Nutrition and enterocutaneous fistulas.
    Makhdoom ZA; Komar MJ; Still CD
    J Clin Gastroenterol; 2000 Oct; 31(3):195-204. PubMed ID: 11033997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of somatostatin in the conservative treatment of external pancreatic fistula].
    Fernández Balaguer P; Suárez Miguelez JM; Galeano Díaz F; Hernández Antequera E; Asensio Prianes L; Urquijo Tomatti H; Rodelgo Lozano M; García-Sancho Martín L
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):222-8. PubMed ID: 2573114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of pancreatic fistulas with somatostatin and total parenteral nutrition.
    Saari A; Schröder T; Kivilaakso E; Kalima T; Lempinen M
    Scand J Gastroenterol; 1989 Sep; 24(7):859-62. PubMed ID: 2572046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Are somatostatin or its synthetic analogues helpful in reducing pancreatic fistula?
    Angst E; Gloor B
    Dig Surg; 2012; 29(6):492-3. PubMed ID: 23392316
    [No Abstract]   [Full Text] [Related]  

  • 53. Octreotide for treatment of postoperative alimentary tract fistulas.
    Paran H; Neufeld D; Kaplan O; Klausner J; Freund U
    World J Surg; 1995; 19(3):430-3; discussion 433-4. PubMed ID: 7639001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Octreotide and enterocutaneous fistula closure in neonates and children.
    Carrera-Guermeur N; Martín-Crespo RM; Ramírez HJ; Pantoja Á; Luque-Mialdea R
    Eur J Pediatr; 2016 Mar; 175(3):305-12. PubMed ID: 26811298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
    Meier R; Dierdorf R; Gyr K
    Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Somatostatin in the medical treatment of fistula of the pancreas and the small intestine].
    Hild P; Stoyanov M; Dobroschke J; Aigner K
    Sem Hop; 1982 Oct; 58(38):2195-8. PubMed ID: 6129704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic surgical complications--the case for prophylaxis.
    Gouillat C; Gigot JF
    Gut; 2001 Dec; 49 Suppl 4(Suppl 4):iv32-9. PubMed ID: 11878792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression.
    Rosenberg L; Dafoe DC; Schwartz R; Campbell DA; Turcotte JG; Tsai ST; Vinik A
    Transplantation; 1987 May; 43(5):764-6. PubMed ID: 2883747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.